1. Home
  2. IMVT vs CCU Comparison

IMVT vs CCU Comparison

Compare IMVT & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMVT
  • CCU
  • Stock Information
  • Founded
  • IMVT 2018
  • CCU 1850
  • Country
  • IMVT United States
  • CCU Chile
  • Employees
  • IMVT N/A
  • CCU N/A
  • Industry
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • CCU Beverages (Production/Distribution)
  • Sector
  • IMVT Health Care
  • CCU Consumer Staples
  • Exchange
  • IMVT Nasdaq
  • CCU Nasdaq
  • Market Cap
  • IMVT 2.7B
  • CCU 2.2B
  • IPO Year
  • IMVT N/A
  • CCU 1992
  • Fundamental
  • Price
  • IMVT $15.53
  • CCU $12.22
  • Analyst Decision
  • IMVT Buy
  • CCU Strong Sell
  • Analyst Count
  • IMVT 11
  • CCU 1
  • Target Price
  • IMVT $33.88
  • CCU $10.00
  • AVG Volume (30 Days)
  • IMVT 1.6M
  • CCU 149.5K
  • Earning Date
  • IMVT 11-06-2025
  • CCU 11-05-2025
  • Dividend Yield
  • IMVT N/A
  • CCU 2.52%
  • EPS Growth
  • IMVT N/A
  • CCU 38.53
  • EPS
  • IMVT N/A
  • CCU 0.44
  • Revenue
  • IMVT N/A
  • CCU $3,254,866,554.00
  • Revenue This Year
  • IMVT N/A
  • CCU $10.29
  • Revenue Next Year
  • IMVT N/A
  • CCU $4.48
  • P/E Ratio
  • IMVT N/A
  • CCU $13.73
  • Revenue Growth
  • IMVT N/A
  • CCU 19.82
  • 52 Week Low
  • IMVT $12.72
  • CCU $10.03
  • 52 Week High
  • IMVT $32.10
  • CCU $15.75
  • Technical
  • Relative Strength Index (RSI)
  • IMVT 46.91
  • CCU 50.81
  • Support Level
  • IMVT $16.08
  • CCU $11.90
  • Resistance Level
  • IMVT $17.20
  • CCU $12.47
  • Average True Range (ATR)
  • IMVT 0.79
  • CCU 0.23
  • MACD
  • IMVT 0.09
  • CCU -0.01
  • Stochastic Oscillator
  • IMVT 36.81
  • CCU 61.64

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

About CCU Compania Cervecerias Unidas S.A.

United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.

Share on Social Networks: